Free Delivery Over $100
|
|
|||
|
||||
Overview"Despite a century of advances in modern medicine, as well as the rapid development of Covid vaccines, the global pharmaceutical industry has largely failed to bring to market drugs that actually cure disease. Why? And looking further ... How can government policies stimulate investment in the development of curative drugs? Is there an untapped potential for ""natural medicines"" in new drug discovery? How have private–public sector partnerships transformed the ways we innovate? To what extent are medicinal plant biodiversity and human health codependent? Addressing this range of increasingly critical questions, Kathryn Ibata-Arens analyzes the rise and decline of the global innovation system for new drug development and proposes a policy framework for fast-tracking the implementation of new discoveries and preparing for future pandemics." Full Product DetailsAuthor: Kathryn C. Ibata-ArensPublisher: Lynne Rienner Publishers Inc Imprint: Lynne Rienner Publishers Inc Edition: New edition Weight: 0.285kg ISBN: 9781626379718ISBN 10: 1626379718 Pages: 217 Publication Date: 30 August 2021 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: In Print  This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsSeries Preface Editorial Advisory Board About the Editors About the Contributors Acknowledgements Introduction Case 1 Finding a Voice: An Elementary Schooler with Autism Spectrum Disorder (ASD) and Down Syndrome Stephanie Meehan and Jane R. Wegner Case 2 Promoting Early Social Communication Skills: A Preschooler with ASD Jill Howard and Geraldine Dawson Case 3 Teaching Social Skills and Self-Regulation to Decrease Problem Behavior and Improve Quality of Life: A Preschooler with ASD Susan M. Wilczynski and Shawnna Sundberg Case 4 Understanding Foundational Developmental Capacities Related to Language: A Toddler with ASD Sima Gerber Case 5 Replacing Challenging Behavior with a Better Way to Communicate: A Fourth Grader with ASD Lauren J. Moskowitz Case 6 Implementing the Joint Attention, Symbolic Play, Engagement and Regulation (JASPER) Intervention: A Toddler with ASD Kyle Sterrett and Connie Kasari Case 7 Using Enhanced Milieu Teaching with an Emerging Verbal Communicator: A Young Child with ASD Ann Kaiser and Jodi K. Heidlage Case 8 Coaching in Early Childhood Intervention: A Toddler with ASD Kathleen D. Ross Case 9 Supporting Relationships and Learning in Secondary School: A Teenager with ASD and Intellectual Disability Erik W. Carter Case 10 Using Pivotal Response Treatment to Improve Social Communication and Behavior Skills: A Young Child with ASD Lynn Kern Koegel, Brittany Lynn Koegel, Elizabeth Ponder, Kristen Strong Case 11 Facilitating Social Communicative and Social Emotional Competence: A Third Grader with ASD Amy C. Laurent, Emily Rubin, and Barry M. Prizant Case 12 Making Friends and Maintaining Relationships: A Preteen with ASD Ashley Brien Case 13 Understanding the Causes and Consequences of One’s Own Challenging Behaviors: An Elementary Schooler with ASD and Attention deficit hyperactivity disorder (ADHD) Tiffany Hutchins and Patricia A. Prelock Case 14 Learning to Approach and Vocalize with Peers During Playground Time Using Self-Modeling: A Preschooler with Moderate to Severe Autism Tom Buggey IndexReviews“A fascinating and enlightening book that resonates singularly with the current pandemic, and also with the environmental crisis. Based on a rich conceptualization and in-depth analysis of various examples, the book invites us to question the effectiveness and sustainability of the Western system of biomedical innovation … and to turn our gaze to alternative innovation systems that are much older but that have renewed relevance in the last decades.” —Etienne Nouguez, Sciences Po Paris Ibata-Arens's accessibly written, and timely, book offers a compelling argument: that profit-and patent-driven drug development must be replaced by a global system of sharing innovation commons, including those harvested from nature. Short of this transformation, pandemics may become more common than we currently imagine! Author InformationKathryn C. Ibata-Arens is Vincent de Paul Professor of Political Economy at DePaul University. Tab Content 6Author Website:Countries AvailableAll regions |
||||
